Clearance of GB virus C during highly active antiretroviral therapy and course of HIV disease progression in HIV-infected patients with hemophilia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 9, 2005, Pages 645-646

  Toyoda, H ^a,b   Honda, T ^a   Katano, Y ^a   Goto, H ^a   Takamatsu, J ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEMOPHILIA; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; PATIENT; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM; VIREMIA;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEMOPHILIA A; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; MALE; RNA, VIRAL; VIREMIA;

EID: 26844527663     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-0020-z     Document Type: Article

References (10)

1. Takamatsu J, Toyoda H, Fukuda Y, Nakano I, Yokozaki S, Hayashi K, Saito H (2001) Effects of HAART on hepatitis C, hepatitis G, and TT virus in multiply coinfected HIV-positive patients with haemophilia. Haemophilia 7:575-581
2. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H (1998) Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17:209-213
3. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ (2000) Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 132:959-963
4. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, Stapleton JT (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345:707-714
5. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345:715-724
6. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, Liu C, Phair J, Margolick JB, Zdunek D, Hess G, Stapleton JT (2004) Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350:981-990
7. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H, Okamoto H (1998) GB virus C/hepatitis G virus isolates in Japanese haemophiliacs and their origins. Thromb Haemost 80:242-245
8. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, Engel AM (1997) Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349:318-320
9. Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE (1998) Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 177:539-542
10. Hanley JP, Jarvis LM, Hayes PC, Lee AJ, Simmonds P, Ludlam CA (1998) Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates. Thromb Haemost 79:291-295